CS logo
small CS logo
Assuta Ashdod

Ashdod, Israel
Hospital in Ashdod
Ha-Refu'a St 7, Ashdod, 7747629
300 Beds

About Assuta Ashdod


Assuta Ashdod Medical Center is a general hospital in Ashdod, Israel. It began operation on June 4, 2017, and was opened in stages, assuming full operation in November 2017. The hospital has 300 beds and serves the population of Ashdod and its suburbs.
There are 300 beds in Assuta Ashdod.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Assuta Ashdod


During the past decade, Assuta Ashdod conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.8% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 1 clinical trials were completed. i.e. 3.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Assuta Ashdod" #1 sponsor was "Assuta Ashdod Hospital" with 6 trials, followed by "Bayer" with 4 trials sponsored, "HaEmek Medical Center, Israel" with 2 trials sponsored, "Karyopharm Therapeutics Inc" with 2 trials sponsored and "ADC Therapeutics S.A." with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Assuta Ashdod" #1 collaborator was "Assuta Ashdod Hospital" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "European Society of Hypertension" with 1 trials as a collaborator and "Gesunder Werra-Meißner-Kreis GmbH" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

Clinical Trials Conditions at Assuta Ashdod


According to Clinical.Site data, the most researched conditions in "Assuta Ashdod" are "Cancer" (2 trials), "Heart Failure" (2 trials), "Myelofibrosis" (2 trials), "Adnexal Torsion" (1 trials) and "Anesthesia, Local" (1 trials). Many other conditions were trialed in "Assuta Ashdod" in a lesser frequency.

Clinical Trials Intervention Types at Assuta Ashdod


Most popular intervention types in "Assuta Ashdod" are "Drug" (22 trials), "Other" (8 trials), "Device" (4 trials), "Diagnostic Test" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Best Available Therapy (BAT)" (2 trials), "Bortezomib" (2 trials), "Finerenone (BAY94-8862)" (2 trials) and "ADLIFE intervention" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Assuta Ashdod


The vast majority of trials in "Assuta Ashdod" are 25 trials for "All" genders, 10 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Assuta Ashdod


Currently, there are NaN active trials in "Assuta Ashdod". 2 are not yet recruiting, 17 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Assuta Ashdod, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Assuta Ashdod, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".